Coffin and coworkers engineered the gene encoding granulocyte macrophage-colony stimulating factor (GM-CSF) in a ∆γ134.5 virus (OncoVEXGM−CSF), to enhance dendritic cell recruitment and boost the host immune response against the tumor [25]. This evidence concerns the gene CSF2 and neoplasm.